Rotterdam, the Netherlands - An abnormally prolonged heart-rate-corrected QT (QTc) interval, compared with a normal one, more than doubled the long-term risk of sudden cardiac death (SCD), independent ...

February 19, 2009 (Portland, Oregon) — Both diabetes and QT-interval-prolonging medications were significant and independent risk factors for sudden cardiac death (SCD) among members of a ...

(HealthDay News) — Use of a computerized clinical decision support system (CDSS) may reduce the risk of prolonged QT c interval in hospitalized patients at risk for torsades de pointes, according to ...

Evaluation of utility of pharmacokinetic studies in phase I combination trials. ApoStream, a novel device for antibody-independent capture of circulating cancercells (CCCs) from blood of patients with ...

Please provide your email address to receive an email when new articles are posted on . More than 13% of users of quetiapine and haloperidol developed severe QT prolongation. Severe QT prolongation ...

A tool predicted whether patients with long QT syndrome (LQTS) are at risk of life-threatening events that could be prevented by an implantable cardioverter-defibrillator (ICD) or beta-blockers. "This ...

MONTREAL, Aug. 25, 2023 /PRNewswire/ - Thryv Therapeutics Inc. today announced positive results of the WAVE 1 Proof of Concept clinical study evaluating LQT-1213 for the reduction of QTcF in ...

SAN DIEGO, INDIANAPOLIS, and WALTHAM, Mass., July 7, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today ...

Please provide your email address to receive an email when new articles are posted on . Treatment with hydroxychloroquine does not impact corrected QT length among patients with rheumatoid arthritis ...

As more consumer-facing devices add features to measure the heart’s electrical activity, companies are looking for new ways to turn this data into valuable health information. AliveCor, a startup that ...